期刊文献+

老年结直肠癌病人化疗耐受性的影响因素分析 被引量:1

Analysis of influencing factors of chemotherapy tolerance in elderly patients with colorectal cancer
下载PDF
导出
摘要 目的探讨影响老年结直肠癌病人化疗耐受性的影响因素,以期为筛选适合化疗的老年肿瘤病人提供一定的依据。方法回顾性分析我院2017~2021年间154例被诊断为结直肠癌且接受化疗的老年病人(年龄≥65岁),以其化疗结果分为化疗耐受良好、化疗基本耐受、化疗不耐受3组,比较3组病人的基础情况、肿瘤情况、营养状况、情感状况、治疗情况等,并以化疗耐受良好为一组,剩余病人为另一组,采用Logistic回归分析影响老年结直肠癌病人化疗耐受性的独立危险因素。结果154例病人中,108例病人化疗耐受良好,27例病人化疗基本耐受,19例病人化疗不耐受。单因素分析提示:各组间年龄、基础疾病数量、肿瘤部位、临床分期、治疗方式、体力状况(PS)评分、营养状况、抑郁状态以及化疗前PLT、Hb、前白蛋白、白蛋白、癌胚抗原(CEA)水平差异有统计学意义。Logistic回归分析显示,肿瘤部位、临床分期、治疗方式、PS评分、营养状况、抑郁状态、Hb、白蛋白、CEA为化疗耐受差的独立影响因素。结论老年结直肠癌病人也应得到积极抗癌治疗,化疗作为主要的抗癌治疗手段,不应以年龄作为简单的判断,Hb、白蛋白、CEA作为化疗耐受性差的独立影响因素可作为有效的参考指标。同时,肿瘤部位、临床分期、治疗方式、PS评分、营养状况、是否抑郁作为独立影响因素也需考虑在内。 Objective To explore the influencing factors of chemotherapy tolerance in the elderly patients with colorectal cancer,in order to provide basis for screening elderly patients suitable for chemotherapy.Methods A retrospective study was conducted among 154 elderly patients(aged≥65 years)who were diagnosed as colorectal cancer and received chemotherapy from 2017 to 2021,and the patients were divided into good chemotherapy tolerance group,basic chemotherapy tolerance group,and chemotherapy intolerance group according to the chemotherapy outcomes.The basic conditions,tumor conditions,nutritional status,emotional conditions and treatment conditions were compared in the three groups.Multivariate regression analysis was further performed to analyze the independent risk factors of chemotherapy tolerance in the elderly patients with colorectal cancer.Results Among 154 patients,108 presented with good chemotherapy tolerance,27 with basic chemotherapy tolerance(70.2%)and 19 with chemotherapy intolerance.Single factor analysis showed that age,number of basic diseases,tumor site,clinical stage,treatment mode,Performance Status(PS)Score,nutritional status,depression,and the levels of platelet,hemoglobin(Hb),prealbumin,albumin and carcinoembryonic antigen(CEA)were significantly different among the groups.Logistic regression analysis showed that tumor site,clinical stage,treatment mode,PS score,nutritional status,depression,Hb,albumin,and CEA were the independent influcencing factors for poor chemotherapy tolerance.Conclusions Elderly patients with colorectal cancer should receive active anti-cancer treatment.Chemotherapy as the main anti-cancer treatment should not be judged simply by age.Hb,albumin and CEA can be used as predictive indicators for prognosis.At the same time,tumor site,clinical stage,treatment mode,PS score,nutritional status and depression should also be considered as the independent influencing factors.
作者 邓仕超 沈浩 孙强 陈佳栋 马保金 DENG Shi-chao;SHEN Hao;SUN Qiang;CHEN Jia-dong;MA Bao-jin(Department of General Surgery,Shanghai Jing’an District Central Hospital,Shanghai 200040,China)
出处 《实用老年医学》 CAS 2023年第5期500-504,共5页 Practical Geriatrics
关键词 结直肠癌 化疗耐受性 老年人 colorectal cancer chemotherapy tolerance aged
  • 相关文献

参考文献1

二级参考文献61

  • 1Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, RebeloM, Parkin DM, Forman D, Bray F. Cancer incidence and mortalityworldwide: sources, methods and major patterns in GLOBOCAN2012. Int J Cancer 2015; 136: E359-E386 [PMID: 25220842 DOI:10.1002/ijc.29210].
  • 2Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Prediction ofcancer incidence and mortality in Korea, 2014. Cancer Res Treat 2014;46: 124-130 [PMID: 24851103 DOI: 10.4143/crt.2014.46.2.124].
  • 3van Steenbergen LN, Elferink MA, Krijnen P, Lemmens VE,Siesling S, Rutten HJ, Richel DJ, Karim-Kos HE, Coebergh JW.Improved survival of colon cancer due to improved treatment anddetection: a nationwide population-based study in The Netherlands1989-2006. Ann Oncol 2010; 21: 2206-2212 [PMID: 20439339DOI: 10.1093/annonc/mdq227].
  • 4Quaglia A, Tavilla A, Shack L, Brenner H, Janssen-Heijnen M,Allemani C, Colonna M, Grande E, Grosclaude P, Vercelli M. Thecancer survival gap between elderly and middle-aged patients inEurope is widening. Eur J Cancer 2009; 45: 1006-1016 [PMID:19121578 DOI: 10.1016/j.ejca.2008.11.028].
  • 5Surgery for colorectal cancer in elderly patients: a systematicreview. Colorectal Cancer Collaborative Group. Lancet 2000; 356:968-974 [PMID: 11041397 DOI: 10.1016/S0140-6736(00)02713-6].
  • 6Potosky AL, Harlan LC, Kaplan RS, Johnson KA, Lynch CF. Age,sex, and racial differences in the use of standard adjuvant therapyfor colorectal cancer. J Clin Oncol 2002; 20: 1192-1202 [PMID:11870160].
  • 7Sundararajan V, Mitra N, Jacobson JS, Grann VR, Heitjan DF,Neugut AI. Survival associated with 5-fluorouracil-based adjuvantchemotherapy among elderly patients with node-positive coloncancer. Ann Intern Med 2002; 136: 349-357 [PMID: 11874307DOI: 10.7326/0003-4819-136-5-200203050-00007].
  • 8Schrag D, Cramer LD, Bach PB, Begg CB. Age and adjuvantchemotherapy use after surgery for stage III colon cancer. J NatlCancer Inst 2001; 93: 850-857 [PMID: 11390534 DOI: 10.1093/jnci/93.11.850].
  • 9Aparicio T, Navazesh A, Boutron I, Bouarioua N, Chosidow D,Mion M, Choudat L, Sobhani I, Mentré F, Soulé JC. Half of elderlypatients routinely treated for colorectal cancer receive a substandardtreatment. Crit Rev Oncol Hematol 2009; 71: 249-257[PMID: 19131256 DOI: 10.1016/j.critrevonc.2008.11.006].
  • 10van Erning FN, van Steenbergen LN, Lemmens VE, Rutten HJ,Martijn H, van Spronsen DJ, Janssen-Heijnen ML. Conditionalsurvival for long-term colorectal cancer survivors in theNetherlands: who do best- Eur J Cancer 2014; 50: 1731-1739[PMID: 24814358 DOI: 10.1016/j.ejca.2014.04.009].

共引文献20

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部